Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Medicina y ciencias biológicas

• Acute Coronary Syndrome 59%
• alogliptin 100%
• Cardiovascular Agents 11%
• Cause of Death 6%
• Confidence Intervals 5%
• Dialysis 7%
• Dipeptidyl-Peptidase IV Inhibitors 22%
• Drug Therapy 4%
• Equivalence Trials 11%
• Glycated Hemoglobin A 8%
• Hospitalization 6%
• Hypoglycemia 8%
• Hypoglycemic Agents 24%
• Incidence 4%
• Myocardial Infarction 12%
• Neoplasms 2%
• Pancreatitis 8%
• Pharmaceutical Preparations 3%
• Placebos 35%
• Random Allocation 8%
• Safety 4%
• Stroke 5%
• Therapeutics 1%
• Type 2 Diabetes Mellitus 44%
• Unstable Angina 9%